Elcriton Overview
- Founded
-
2008
- Status
-
Acquired/Merged
- Employees
-
8
- Latest Deal Type
-
M&A
- Financing Rounds
-
3
Elcriton General Information
Description
Developer of biochemical technologies. The company is specialized in commercializing of technologies that supplant fossil fuel consumption, reduce green house gas emissions and accelerate the expansion of cleantech industries in the United States.
Contact Information
Website
www.elcriton.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Other Commercial Services
Other Commercial Products
Acquirer
Primary Office
- 15 Reads Way
- Suite 106
- New Castle, DE 19720
- United States
Elcriton Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Elcriton Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Terry Papoutsakis Ph.D | President & Founder | ||
| Bryan Tracy Ph.D | Chief Executive Officer & Lead Scientist |
Elcriton Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Elcriton Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|